Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

AgeX Therapeutics Q1 EPS $(0.09) Down From $(0.07) YoY, Sales $10.00K Up From $5.00K YoY

Author: Happy Mohamed | May 12, 2023 04:07pm
AgeX Therapeutics (AMEX:AGE) reported quarterly losses of $(0.09) per share. This is a 28.57 percent decrease over losses of $(0.07) per share from the same period last year. The company reported $10.00 thousand in sales this quarter. This is a 100.00 percent increase over sales of $5.00 thousand the same period last year.

Posted In: AGE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist